Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alpha-particle emitter (225Ac)-labeled Herceptin antibody targeting of breast cancer: Efficacy vs HER-2/neu expression
    Meeting Abstract

    Ballangrud, A. M.; Yang, W.; Enmon, R. M.; Pellegrini, V. A.; Palm, S.; Borchardt, P. E.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
    Meeting Abstract

    Kelly, W.; O'connor, O.; Richon, V. M.; Tong, W.; Rao, T. D.; Chiao, J.; O'Brien, J. P.; Rifkind, R. A.; Marks, P. A.; Scher, H. I.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • Xenogeneic DNA immunization against CD20 elicits immune responses and confers modest tumor protection in a mouse model of lymphoma
    Meeting Abstract

    Palomba, M. L.; Roberts, W. K.; Scheinberg, D. A.; Houghton, A. N.
    Blood (2002)

    Fulltext@MSK | Save
  • In vivo anti-tumor activity of genetically modified T cells is dependent on the method of ex vivo T cell expansion
    Meeting Abstract

    Brentjens, R. J.; Latouche, J. B.; Riviere, I.; Sadelain, M.
    Blood (2002)

    Fulltext@MSK | Save
  • Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients
    Meeting Abstract

    Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia
    Meeting Abstract

    Weiss, M. A.; Lamanna, N.; Gencarelli, A.; Scheinberg, D. A.; Maslak, P. G.; Horgan, D.
    Blood (2002)

    Fulltext@MSK | Save
  • Sequential cytarabine and alpha-particle immunotherapy with Bismuth-213-labeled anti-CD33 monoclonal antibody HuM195 in acute myeloid leukemia (AML)
    Meeting Abstract

    Burke, J. M.; Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (2002)

    Fulltext@MSK | Save
  • PKC412, an oral FLT3 inhibitor, has activity in mutant FLT3 acute myeloid leukemia (AML): A phase II clinical trial
    Meeting Abstract

    Stone, R. M.; Klimek, V.; DeAngelo, D. J.; Nimer, S.; Estey, E.; Galinsky, I.; Neuberg, D.; Yap, A.; Fox, E. A.; Gilliland, D. G.; more...
    Blood (2002)

    Fulltext@MSK | Save
  • Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapy
    Journal Article

    Dombret, H.; Fenaux, P.; Soignet, S. L.; Tallman, M. S.
    Seminars in Hematology (2002)

    Fulltext@MSK | Save
  • A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia
    Journal Article

    Weiss, M. A.; Aliff, T. B.; Tallman, M. S.; Frankel, S. R.; Kalaycio, M. E.; Maslak, P. G.; Jurcic, J. G.; Scheinberg, D. A.; Roma, T. E.
    Cancer (2002)

    Fulltext@MSK | Save